Dr. Warren Marks, MD

NPI: 1285727370
Total Payments
$201,930
2024 Payments
$5,503
Companies
19
Transactions
258

Payment Breakdown by Category

Other$92,265 (45.7%)
Consulting$78,066 (38.7%)
Travel$23,602 (11.7%)
Food & Beverage$7,869 (3.9%)
Education$130.01 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $83,835 35 41.5%
Consulting Fee $78,066 22 38.7%
Travel and Lodging $23,602 78 11.7%
Honoraria $8,430 3 4.2%
Food and Beverage $7,869 115 3.9%
Education $130.01 5 0.1%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $123,023 136 $0 (2024)
Sarepta Therapeutics, Inc. $33,520 38 $0 (2024)
PTC Therapeutics, Inc. $27,791 30 $0 (2024)
CATALYST PHARMACEUTICALS, INC. $4,866 9 $0 (2024)
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $4,530 2 $0 (2023)
Genentech USA, Inc. $3,974 4 $0 (2019)
Neurocrine Biosciences, Inc. $1,480 12 $0 (2023)
Genentech, Inc. $904.96 4 $0 (2023)
Ipsen Biopharmaceuticals, Inc $650.44 8 $0 (2023)
Medtronic USA, Inc. $340.55 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,503 18 CATALYST PHARMACEUTICALS, INC. ($4,866)
2023 $5,641 21 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($2,826)
2022 $17,758 16 Sarepta Therapeutics, Inc. ($17,510)
2021 $5,024 4 PTC Therapeutics, Inc. ($5,000)
2020 $15,354 6 PTC Therapeutics, Inc. ($9,750)
2019 $8,710 12 PTC Therapeutics, Inc. ($4,409)
2018 $89,079 103 Biogen, Inc. ($74,265)
2017 $54,861 78 Biogen, Inc. ($48,606)

All Payment Transactions

258 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
11/13/2024 ITF Therapeutics LLC Food and Beverage In-kind items and services $16.84 General
10/18/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Honoraria Cash or cash equivalent $3,900.00 General
Category: NEUROLOGY
10/10/2024 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $8.21 General
Category: Neurology
09/28/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Food and Beverage Cash or cash equivalent $75.00 General
Category: NEUROLOGY
09/28/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Food and Beverage Cash or cash equivalent $50.00 General
Category: NEUROLOGY
09/28/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Travel and Lodging Cash or cash equivalent $34.19 General
Category: NEUROLOGY
09/28/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: NEUROLOGY
09/27/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Travel and Lodging Cash or cash equivalent $357.96 General
Category: NEUROLOGY
09/27/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Travel and Lodging Cash or cash equivalent $181.26 General
Category: NEUROLOGY
09/27/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Food and Beverage Cash or cash equivalent $124.95 General
Category: NEUROLOGY
09/27/2024 CATALYST PHARMACEUTICALS, INC. AGAMREE (Drug) Travel and Lodging Cash or cash equivalent $117.84 General
Category: NEUROLOGY
09/11/2024 Sarepta Therapeutics, Inc. Food and Beverage In-kind items and services $97.48 General
08/22/2024 Biogen, Inc. SKYCLARYS (Drug) Food and Beverage In-kind items and services $9.82 General
Category: Neurology
03/05/2024 Sarepta Therapeutics, Inc. Food and Beverage In-kind items and services $130.47 General
03/05/2024 Sarepta Therapeutics, Inc. Travel and Lodging In-kind items and services $110.31 General
03/05/2024 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $23.77 General
Category: Neurology
03/04/2024 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $110.05 General
Category: Neurology
03/03/2024 PTC Therapeutics, Inc. Food and Beverage In-kind items and services $130.30 General
11/17/2023 Genentech, Inc. Evrysdi (Drug) Travel and Lodging In-kind items and services $293.00 General
Category: Neurology
11/16/2023 Genentech, Inc. Evrysdi (Drug) Food and Beverage In-kind items and services $394.00 General
Category: Neurology
11/15/2023 Genentech, Inc. Evrysdi (Drug) Food and Beverage In-kind items and services $185.00 General
Category: Neurology
10/05/2023 BioMarin Pharmaceutical Inc. Brineura (Biological) Food and Beverage In-kind items and services $118.64 General
Category: CLN 2
09/12/2023 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $40.53 General
09/11/2023 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $99.07 General
Category: Neurology
06/14/2023 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ZOLGENSMA (Biological) Honoraria Cash or cash equivalent $2,825.50 General
Category: GENE THERAPY

About Dr. Warren Marks, MD

Dr. Warren Marks, MD is a Pediatrics healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285727370.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Marks, MD has received a total of $201,930 in payments from pharmaceutical and medical device companies, with $5,503 received in 2024. These payments were reported across 258 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,835).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Neurology with Special Qualifications in Child Neurology
  • Location Fort Worth, TX
  • Active Since 10/02/2006
  • Last Updated 02/10/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1285727370

Products in Payments

  • SPINRAZA (Biological) $115,502
  • EXONDYS 51 (Drug) $11,753
  • TECFIDERA (Drug) $5,922
  • AGAMREE (Drug) $4,866
  • ZOLGENSMA (Biological) $4,530
  • Emflaza (Drug) $4,085
  • Non-Covered Product (Drug) $3,974
  • EMFLAZA (Drug) $1,350
  • Evrysdi (Drug) $904.96
  • Dysport 300 U-1 (Drug) $303.40
  • Dysport (Drug) $239.70
  • Brineura (Biological) $188.77
  • VNS Therapy (Device) $137.21
  • Epidiolex (Drug) $125.79
  • ACTIVA (Device) $125.38
  • Fintepla (Drug) $125.00
  • SYNCHROMED (Device) $111.33
  • DYSPORT (Drug) $107.34
  • LIORESAL (Device) $103.84
  • DISEASE STATE (Drug) $100.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Fort Worth